Total Payments
$16,906
2024 Payments
$1,928
Companies
60
Transactions
1,170
Medicare Patients
1,556
Medicare Billing
$152,717
Payment Breakdown by Category
Food & Beverage$16,867 (99.8%)
Education$38.80 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,867 | 1,166 | 99.8% |
| Education | $38.80 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,564 | 89 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,515 | 105 | $0 (2024) |
| Novo Nordisk Inc | $1,455 | 119 | $0 (2024) |
| ABBVIE INC. | $1,275 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,273 | 81 | $0 (2024) |
| Lilly USA, LLC | $1,266 | 102 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,178 | 75 | $0 (2023) |
| Amgen Inc. | $811.86 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $690.39 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $602.01 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,928 | 112 | Novo Nordisk Inc ($317.90) |
| 2023 | $1,893 | 129 | GlaxoSmithKline, LLC. ($364.43) |
| 2022 | $2,228 | 152 | ABBVIE INC. ($307.06) |
| 2021 | $2,231 | 142 | AbbVie Inc. ($444.98) |
| 2020 | $1,784 | 126 | Allergan, Inc. ($250.95) |
| 2019 | $2,138 | 138 | AstraZeneca Pharmaceuticals LP ($289.19) |
| 2018 | $2,103 | 161 | SANOFI-AVENTIS U.S. LLC ($301.15) |
| 2017 | $2,602 | 210 | SANOFI-AVENTIS U.S. LLC ($279.22) |
All Payment Transactions
1,170 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 336 | 479 | $78,212 | $33,065 |
| 2022 | 8 | 370 | 527 | $88,561 | $37,797 |
| 2021 | 10 | 426 | 635 | $103,859 | $45,229 |
| 2020 | 10 | 424 | 590 | $95,445 | $36,626 |
Total Patients
1,556
Total Services
2,231
Medicare Billing
$152,717
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 246 | $50,676 | $17,752 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $15,725 | $10,259 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 47 | $6,580 | $2,181 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $2,544 | $1,709 | 67.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,176 | $811.72 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 20 | $720.00 | $190.40 | 26.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $686.00 | $114.51 | 16.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 15 | $105.00 | $48.15 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 272 | $56,032 | $19,426 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 84 | 84 | $15,540 | $10,449 | 67.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $4,020 | $2,398 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 53 | $7,420 | $2,194 | 29.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 29 | 30 | $3,180 | $2,043 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 39 | $1,638 | $1,069 | 65.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 17 | $612.00 | $162.68 | 26.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 16 | 17 | $119.00 | $54.86 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 332 | $68,392 | $25,827 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 81 | 81 | $14,985 | $10,293 | 68.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 35 | 36 | $3,816 | $2,328 | 61.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 43 | $6,020 | $2,322 | 38.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 16 | $3,856 | $1,622 | 42.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 17 | $3,400 | $1,507 | 44.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 50 | 51 | $2,142 | $806.87 | 37.7% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 12 | 17 | $374.00 | $256.19 | 68.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 18 | 20 | $720.00 | $194.20 | 27.0% |
About Dr. Yushen Lee, M.D
Dr. Yushen Lee, M.D is a Family Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467449009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yushen Lee, M.D has received a total of $16,906 in payments from pharmaceutical and medical device companies, with $1,928 received in 2024. These payments were reported across 1,170 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($16,867).
As a Medicare-enrolled provider, Lee has provided services to 1,556 Medicare beneficiaries, totaling 2,231 services with total Medicare billing of $152,717. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Baton Rouge, LA
- Active Since 09/29/2005
- Last Updated 01/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1467449009
Products in Payments
- FARXIGA (Drug) $1,016
- TRELEGY ELLIPTA (Drug) $931.41
- JARDIANCE (Drug) $858.47
- VRAYLAR (Drug) $825.51
- TRULICITY (Drug) $520.31
- TRINTELLIX (Drug) $518.91
- Ozempic (Drug) $512.54
- UBRELVY (Drug) $503.24
- TOUJEO (Drug) $475.46
- TRADJENTA (Drug) $385.15
- XARELTO (Drug) $347.43
- MOUNJARO (Drug) $316.53
- Victoza (Drug) $315.33
- VYVANSE (Drug) $314.62
- JANUVIA (Drug) $296.66
- SOLIQUA 100/33 (Biological) $261.88
- CHANTIX (Drug) $258.94
- Kerendia (Drug) $258.16
- Aimovig (Biological) $233.50
- SOLIQUA (Drug) $223.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baton Rouge
Dr. Susan Julius, Md, MD
Family Medicine — Payments: $177,846
Family Medicine $177,846
Dr. Christine Smith, Md, MD
Family Medicine — Payments: $104,714
Family Medicine $104,714
Myles Jaynes, D.o, D.O
Family Medicine — Payments: $18,709
Family Medicine $18,709
Dr. Gerald Barber, M.d, M.D
Family Medicine — Payments: $18,510
Family Medicine $18,510
Dr. Stan Mays, M.d, M.D
Family Medicine — Payments: $17,123
Family Medicine $17,123
Dr. Donald Carson, D.o, D.O
Family Medicine — Payments: $15,182
Family Medicine $15,182